Although we discovered that lipogenesis-upregulated interleukin-33 (IL-33) expression in astrocytes in the peri-infarct lead to BBB repair after stroke [7], manipulating the key driving enzyme fatty acid synthase (FASN) to enhance lipogenesis was very challenging, as the activator of FASN has been lacking. This evidence concerns the gene IL33 and stroke disorder.